[Bacterial infections in neutropenic patients with cancer].
This paper shows the predisposing factors for infection in neutropenic patients with cancer, and the use of antibiotics in empirical antibacterial therapy. The role of glicopeptide and the fourth generation of cephalosporis in monotherapy and dualtherapy in empirical treatment of febrile neutropenia is also discussed.
Matysiak
Michał
M
Katedra i Klinika Pediatrii, Hematologii i Onkologii Akademii Medycznej w Warszawie, Warszawa, ul. Marszałkowska 24. mmatysiak@litewska.edu.pl
D000900:Anti-Bacterial Agents; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*
D000900:Anti-Bacterial Agents